Bristol-Myers Squibb Co (NYSE:BMY)
| 66.96 Delayed Data As of 4:00pm ET |  -0.28 / -0.42%Today’s Change | 65.28 Today|||52-Week Range 81.44 | -6.94% Year-to-Date |
Latest BMY News | Press Releases
Today’s Trading
| Previous close | 67.24 |
| Today’s open | 67.90 |
| Day’s range | 66.65 - 67.90 |
| Volume | 6,723,635 |
| Average volume (3 months) | 8,769,611 |
| Market cap | $142.7B |
Data as of 4:00pm ET, 03/23/2023
Growth & Valuation
| Earnings growth (last year) | -5.67% |
| Earnings growth (this year) | +4.43% |
| Earnings growth (next 5 years) | +3.00% |
| Revenue growth (last year) | -0.49% |
| P/E ratio | 22.7 |
| Price/Sales | 3.35 |
| Price/Book | 4.53 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| SNYSanofi | +2.91 | +5.96% |
| NVSNovartis | +0.55 | +0.67% |
| REGNRegeneron Pharmaceut... | +50.40 | +6.71% |
| ---- |
Data as of 4:00pm ET, 03/23/2023
Financials
| Next reporting date | April 27, 2023 |
| EPS forecast (this quarter) | $1.99 |
| Annual revenue (last year) | $46.2B |
| Annual profit (last year) | $6.3B |
| Net profit margin | 13.71% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters New York, New York |
Forecasts
